Deutsche Bank lowered the firm’s price target on Quest Diagnostics to $125 from $140 and keeps a Hold rating on the shares post the earnings report.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DGX:
- Quest Diagnostics Announces 5.6% Quarterly Dividend Hike
- Quest Diagnostics increases quarterly dividend 5.6% to 75c per share
- Quest Diagnostics sees FY24 adjusted EPS $8.60-$8.90, consensus $8.99
- Quest Diagnostics reports Q4 EPS $2.15, consensus $2.11
- Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share